Doctor of Osteopathy Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Stephen Dalm

Obstetrics & Gynecology Grand Rapids, MI Doctor of Osteopathy

NPI 1114028255 CMS profile 141409

5060 Cascade Rd Se, Ste C, Grand Rapids, MI 49546

Open in the dashboard

General payments

$47,661

258 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Stephen Dalm of Grand Rapids, MI is reported in the CMS Open Payments database as having received $47,661 across 258 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $14,010 19
2022 General $6,689 34
2021 General $2,456 63
2020 General $1,617 44
2019 General $22,889 98

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stephen Dalm
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Stephen Dalm were reported at $0. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year Stephen Dalm Obstetrics & Gynecology median Middle half National median
2019 $22,889 $172 $62–$391 $163
2020 $1,617 $94 $36–$222 $114
2021 $2,456 $136 $42–$369 $132
2022 $6,689 $160 $50–$433 $149
2023 $14,010 $169 $56–$423 $160
2024 $0 $152 $50–$371 $164
2025 $0 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Organon LLC $20,222 28 payments
  2. AbbVie, Inc. $16,783 87 payments
  3. Merck Sharp & Dohme Corporation $7,646 18 payments
  4. Minerva Surgical, Inc $1,081 7 payments
  5. Novo Nordisk Inc $361 32 payments
  6. Allergan Inc. $193 12 payments
  7. Axonics Modulation Technologies, Inc. $116 5 payments
  8. Pfizer Inc. $115 6 payments
  9. Daiichi Sankyo Inc. $112 6 payments
  10. Vermillion, Inc. $99 1 payment
  11. Other $933 56 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $21,625 16 payments
  2. Compensation for serving as faculty or as a speaker for a medical education program $20,203 27 payments
  3. Food and Beverage $4,051 197 payments
  4. Travel and Lodging $1,739 15 payments
  5. Education $43 3 payments
Products named General payments · program years 2019–2023
  1. NEXPLANON Etonogestrel $20,203 27 payments
  2. Orilissa Endocrinology $15,184 44 payments
  3. NEXPLANON Womens Health $7,646 18 payments
  4. ORIAHNN $1,287 21 payments
  5. Endometrial Ablation System (Device) $1,049 5 payments
  6. ORILISSA Womens Health $468 25 payments
  7. Saxenda $295 26 payments
  8. LO LOESTRIN FE $169 11 payments
  9. LILETTA $148 11 payments
  10. BOTOX $133 8 payments
  11. Other $1,952 112 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

258 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record